PRPF40A
Basic information
Region (hg38): 2:152651593-152718012
Previous symbols: [ "FNBP3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRPF40A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 0 | 1 |
Variants in PRPF40A
This is a list of pathogenic ClinVar variants found in the PRPF40A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-152657909-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
2-152657983-T-C | not specified | Uncertain significance (Jul 27, 2021) | ||
2-152659162-G-T | not specified | Uncertain significance (Oct 12, 2022) | ||
2-152659277-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
2-152664205-T-C | Benign (Jan 30, 2018) | |||
2-152669159-C-T | not specified | Uncertain significance (Oct 06, 2024) | ||
2-152669254-A-T | not specified | Uncertain significance (Jan 06, 2023) | ||
2-152669267-A-G | not specified | Uncertain significance (Nov 16, 2021) | ||
2-152670345-C-T | not specified | Uncertain significance (May 20, 2024) | ||
2-152670383-TATAGCA-T | Benign (Jan 30, 2018) | |||
2-152671338-T-C | not specified | Uncertain significance (Mar 13, 2023) | ||
2-152671367-A-G | not specified | Uncertain significance (Sep 03, 2024) | ||
2-152672537-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
2-152672621-G-A | not specified | Uncertain significance (Sep 10, 2024) | ||
2-152676556-T-C | not specified | Uncertain significance (Oct 26, 2021) | ||
2-152676645-G-C | not specified | Uncertain significance (Jun 30, 2023) | ||
2-152676669-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
2-152676672-G-C | not specified | Uncertain significance (Nov 28, 2023) | ||
2-152676725-A-C | not specified | Uncertain significance (Dec 03, 2021) | ||
2-152679095-T-C | not specified | Uncertain significance (Jun 28, 2024) | ||
2-152679382-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
2-152693043-G-A | not specified | Uncertain significance (Sep 12, 2024) | ||
2-152693053-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
2-152694586-T-A | not specified | Uncertain significance (Oct 07, 2024) | ||
2-152716063-T-C | not specified | Uncertain significance (Apr 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRPF40A | protein_coding | protein_coding | ENST00000410080 | 26 | 66405 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0391 | 0.961 | 124621 | 0 | 17 | 124638 | 0.0000682 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.33 | 261 | 463 | 0.564 | 0.0000236 | 6128 |
Missense in Polyphen | 14 | 36.443 | 0.38416 | 440 | ||
Synonymous | -2.52 | 181 | 143 | 1.27 | 0.00000703 | 1604 |
Loss of Function | 5.10 | 14 | 54.7 | 0.256 | 0.00000291 | 738 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000946 | 0.0000936 |
Ashkenazi Jewish | 0.000203 | 0.000199 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000109 | 0.000106 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000341 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to WASL/N-WASP and suppresses its translocation from the nucleus to the cytoplasm, thereby inhibiting its cytoplasmic function (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. May play a role in cytokinesis. May be involved in pre-mRNA splicing. {ECO:0000250, ECO:0000269|PubMed:21834987}.;
- Pathway
- Spliceosome - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in squamous cell - TarBase;mRNA Processing;Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.299
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.72
Haploinsufficiency Scores
- pHI
- 0.461
- hipred
- Y
- hipred_score
- 0.625
- ghis
- 0.699
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.922
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prpf40a
- Phenotype
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;cytoskeleton organization;cell cycle;regulation of cell shape;cell migration;regulation of cytokinesis;mRNA cis splicing, via spliceosome;cell division
- Cellular component
- nucleoplasm;U1 snRNP;cytosol;membrane;nuclear matrix;nuclear speck;U2-type prespliceosome
- Molecular function
- RNA binding;protein binding